[an error occurred while processing this directive] | [an error occurred while processing this directive]
Effects of LEF1 and CTNNB1 on cycle arrest, apoptosis and radiation resistance of esophageal carcinoma cells
Ge Dahe1, Liu Yaqing1, Nan Jun1, Li Jian2, Ding Hui2, QiaoShulin3, An Yuan4, Xu Chunjin1
1Department of Gastroenterology,Shangqiu First People's Hospital,Shangqiu 476100,China; 2Department of Gastroenterology,Henan Provincial People's Hospital,Zhengzhou 450003,China; 3Department of Oncology and Radiotherapy,Shangqiu First People's Hospital,Shangqiu 476100,China; 4Outpatient Department ofChina Institute of Water Resources and Hydropower Research,Beijing 100038,China
AbstractObjective To investigate the relationship between the expression level of lymphocyte enhancer-binding factor 1(LEF1) and CTNNB1 and the cycle arrest, apoptosis and radiation resistance of esophageal cancer cells and unravel the related mechanisms. Methods Recombinantplasmids and empty plasmids expressing LEF1 and CTNNB1were constructed and transfected into esophageal cancer cells. RT-PCR assay was used to detect the transfection efficiency of the plasmids. Clone formation assay, CCK8 assay, cell cycle test by flow cytometry, apoptosis test by flow cytometry and Western blot were performed to detect the differences in theradioresistance, proliferation, cell cycle and apoptosis of esophageal cancer cells before and after transfection. Results The survival rate of clonal colony cells in the pGEX-LEF1+pCMV6-CTNNB1 group was significantly better than those in other groups (P<0.05). The proliferation of clonal colony cellsat 72h, 96h and 120h in the pGEX-LEF1+pCMV6-CTNNB1 group was significantly better than those in the pGEX+pCMV6,pGEX-LEF1+pCMV6 and pCMV6-CTNNB1+pGEX groups (all P<0.05). The percentage of G2 phase arrest cells in the pGEX-LEF1+pCMV6-CTNNB1 group was significantly higher than those in the other groups (all P<0.05). The apoptosis rate of esophageal cancer cells in the pGEX-LEF1+pCMV6-CTNNB1 group was significantly lower compared with those in the pGEX+pCMV6, pGEX-LEF1+pCMV6 and pCMV6-CTNNB1+pGEX groups (all P<0.05). The expression levels of Bax and Caspase 3 proteins in the pGEX-LEF1+pCMV6-CTNNB1 group were significantly lower than those in the pGEX+pCMV6, pGEX-LEF1+pCMV6 and pCMV6-CTNNB1+pGEX groups (all P<0.05). The expression level of Bcl-2 protein in the pGEX-LEF1+pCMV6-CTNNB1 group was significantly higher compared with those in the other groups (all P<0.05). Conclusion LEF1 and CTNNB1 can regulate the proliferation and G2 phase arrest of esophageal cancer cells after radiation intervention by mediating the Wnt signaling pathway, and improve the radiation resistance of esophageal cancer cells by inhibiting cell apoptosis.
Fund:Science and Technology Development Plan of Henan Province in 2019(192102310320)
Corresponding Authors:
An Yuan,Email:anyuan0220@126.com;Xu Chunjin,Email:xuchunjin120600@163.com
Cite this article:
Ge Dahe,Liu Yaqing,Nan Jun et al. Effects of LEF1 and CTNNB1 on cycle arrest, apoptosis and radiation resistance of esophageal carcinoma cells[J]. Chinese Journal of Radiation Oncology, 2022, 31(4): 376-382.
Ge Dahe,Liu Yaqing,Nan Jun et al. Effects of LEF1 and CTNNB1 on cycle arrest, apoptosis and radiation resistance of esophageal carcinoma cells[J]. Chinese Journal of Radiation Oncology, 2022, 31(4): 376-382.
[1] Xu F, Gu J, Wang L, et al. Up-regulation of EIF3e is associated with the progression of esophageal squamous cell carcinoma and poor prognosis in patients[J]. J Cancer, 2018, 9(7):1135-1144. DOI:10.7150/jca.22546. [2] Hu Y, Guo X, Wang J, et al. A novel microRNA identified in hepatocellular carcinomas is responsive to LEF1 and facilitates proliferation and epithelial-mesenchymal transition via targeting of NFIX[J]. Oncogenesis, 2018, 7(2):22. DOI:10.1038/s41389-017-0010-x. [3] Luo J, Wang W, Tang Y, et al. mRNA and methylation profiling of radioresistant esophageal cancer cells:the involvement of sall2 in acquired aggressive phenotypes[J]. J Cancer, 2017, 8(4):646-656. DOI:10.7150/jca.15652. [4] 展晖, 安媛, 任民柱, 等. 经典Wnt通路与食管癌细胞放射抵抗相关关系探讨[J]. 中华放射肿瘤学杂志, 2021, 30(6):614-618. DOI:10.3760/cma.j.cn113030-20200915-00466. Zhan H, An Y, Ren MZ, et al. Study on the relationship between classical Wnt pathway and radiation resistance of esophageal carcinoma cells[J]. Chin J Radiat Oncol, 2021, 30(6):614-618. DOI:10.3760/cma.j.cn113030-20200915-00466. [5] Zhao DX,Lu A,Wang LF. Expression and clinical significance of HMGB1 in esophageal cancer:AMeta-analysis[J]. Chinese Journal of Cancer Prevention and Treatment,2018,25(6):442-448. [6] Xia D, Zhang XR, Ma YL, et al. Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CAMKⅡα-associated activation of autophagy[J]. Cell Biosci, 2020, 10:90. DOI:10.1186/s13578-020-00456-6. [7] Jin J, Guo Y, Dong X, et al. Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency[J]. Radiother Oncol, 2020, 150:104-113. DOI:10.1016/j.radonc.2020.06.022. [8] Zhang G, Wang X, Xue Q. Combined targeted ion channel therapy:can it be an alternative choice for esophageal cancer patients?[J]. Med Hypotheses, 2018, 117:59-62. DOI:10.1016/j.mehy.2018.06.010. [9] Li ZY, Li HF, Zhang YY, et al. Value of long non-coding RNA Rpph1 in esophageal cancer and its effect on cancer cell sensitivity to radiotherapy[J]. World J Gastroenterol, 2020, 26(15):1775-1791. DOI:10.3748/wjg.v26.i15.1775. [10] Melsens E, De Vlieghere E, Descamps B, et al. Hypoxia imaging with (18) F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts[J]. Radiat Oncol, 2018, 13(1):39. DOI:10.1186/s13014-018-0984-3. [11] Zhou S, Liu S, Lin C, et al. TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ[J]. Oncogene, 2020, 39(18):3710-3725. DOI:10.1038/s41388-020-1245-0. [12] Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer:update on effectors and inhibitors[J]. Cancer Treat Rev, 2018, 62:50-60. DOI:10.1016/j.ctrv.2017.11.002. [13] Xun J,Wang C,Yao J,et al. CircBAN Pact sasasponge of let-7 at opromotegastric cancer progression viatheFZD5/Wnt/β-catenin pathway[J]. RSCAdv,2020,10(12):7221-7231. [14] Koval A, Katanaev VL. Dramatic dysbalancing of the Wnt pathway in breast cancers[J]. Sci Rep, 2018, 8(1):7329. DOI:10.1038/s41598-018-25672-6. [15] Yin H, Wang X, Zhang X, et al. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1degradation[J]. Cancer Lett, 2020, 494:121-131. DOI:10.1016/j.canlet.2020.06.005. [16] Yue X, Lan F, Xia T. Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt/β-catenin signaling and promotes radiation resistance by targeting TCEAl7[J]. Mol Ther, 2019, 27(11):1939-1949. DOI:10.1016/j.ymthe.2019.07.011. [17] He Y, Yuan X, Zuo H, et al. Berberine exerts a protective effect on gut-vascular barrier via the modulation of the Wnt/beta-catenin signaling pathway during sepsis[J]. Cell PhysiolBiochem, 2018, 49(4):1342-1351. DOI:10.1159/000493412. [18] Liu L,Zhu H,Liao Y,et al. Inhibition of Wnt/β-catenin pathway reverses multi-drugresistance and EMTinOct4+/Nanog+NSCLCcells[J]. Biomed Pharmacother,2020,127:110225. [19] Qiu J, Hao Y, Huang S, et al. miR-557 works as a tumor suppressor in human lung cancers by negatively regulating lef1 expression[J]. Tumour Biol, 2017, 39(6):1010428317709467. DOI:10.1177/1010428317709467. [20] Mohindra S, Sakr H, Sturgis C, et al. LEF-1 is a sensitive marker of cribriform morular variant of papillary thyroid carcinoma[J]. Head Neck Pathol, 2018, 12(4):455-462. DOI:10.1007/s12105-017-0873-3. [21] Wen J, Min X, Shen M, et al. ACLY facilitates colon cancer cell metastasis by CTNNB1[J]. J Exp Clin Cancer Res, 2019, 38(1):401. DOI:10.1186/s13046-019-1391-9. [22] 黄晓智, 熊伟, 刘洋, 等. 食管鳞癌中β-catenin及淋巴细胞结合增强因子1的表达及其与近期放疗疗效的关系[J]. 中国临床研究, 2020, 33(9):1193-1196. DOI:10.13429/j.cnki.cjcr.2020.09.010. Huang XZ, Xiong W, Liu Y, et al. Expression of β-catenin and lymphocyte binding enhancer factor 1 in esophageal squamous cell carcinoma and its relationship with recent radiotherapy efficacy[J]. Chin J Clin Res, 2020,33(9):1193-1196. DOI:10.13429/j.cnki.cjcr.2020.09.010.
2022, Vol. 31 
